NEW YORK (Reuters Health) Jul 16 –
In patients with juvenile idiopathic arthritis (JIA), final height may depend upon the severity of growth retardation during the active phase of the disease and on catch-up growth after the discontinuation of prednisone, French researchers report.
Dr. Dominique Simon from H pital Robert Debr , Paris, and colleagues measured the height of 24 children with JIA, mean 3.5 years of age at the start of therapy. Height was expressed as the height standard deviation score for chronological age (HSDS/CA). The researchers compared the patient’s final height with reference values for the French population and to target height. Patients were followed for a mean of 13.6 years.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!